Mode
Text Size
Log in / Sign up
N/A Completed N=94 Randomized Double-blind Treatment

Acupuncture for Fatigue in Parkinson's Disease

Source: ClinicalTrials.gov NCT01360229 ↗
Enrolled (actual)
94
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcomePrimary: Change in the Modified Fatigue Impact Scale Total (MFIS) Between Treatment Groups — -13.2; -16.0 units on a scale

Summary

This is a single-center, double-blind, placebo-controlled trial to see if acupuncture can safety and effectively treat fatigue in Parkinson's Disease (PD). Eligible subjects will receive either real or sham acupuncture twice weekly for six weeks.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in the Modified Fatigue Impact Scale Total (MFIS) Between Treatment Groups
-13.2; -16.0

Eligibility Criteria

Inclusion Criteria

  • Patients with PD
  • Patients 40-99 years of age
  • Patients who have significant fatigue
  • Patients must be on a stable medication regimen for the treatment of PD

Exclusion Criteria

  • Patients who have had previous acupuncture within the past six months
  • Patients who have had deep brain stimulation (DBS)
  • Patients with dementia, depression, or sleep disorder
  • Patients who are currently taking medications known to affect fatigue, such as stimulants
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01360229). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search